Output details
4 - Psychology, Psychiatry and Neuroscience
University of Cambridge
Article title
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
Type
D - Journal article
Title of journal
The Lancet Neurology
Article number
-
Volume number
11
Issue number
2
First page of article
150
ISSN of journal
14744422
Year of publication
2012
URL
-
Number of additional authors
13
Additional information
Justification Statement(a): the author made a substantial contribution either to
(i) the conception and design of the study;
(ii) to the organisation and conduct of the study;
(iii) to carrying out the study (including acquisition of study data;
(iv) to analysis and interpretation of study data);
and
(b): The author helped
(i) draft the output
(ii) critiqued the output for important intellectual content.
Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
52
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-